A study to find the effectiveness of two drugs, Diclofenac and Buprenorphine to help relieve pain in patients who develop acute inflammation of the pancreas, namely pancreatitis
Phase 4
Completed
- Conditions
- Health Condition 1: K859- Acute pancreatitis, unspecified
- Registration Number
- CTRI/2020/07/026914
- Lead Sponsor
- Mayank Saini
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Acute pancreatitis as defined by the clinical symptoms, elevation in serum amylase level(more than three times the upper limit of normal range) or imaging finding
Abdominal pain at the time of enrolment
Patients who have presented to the hospital within the first 5 days after onset of pain.
Exclusion Criteria
Pregnancy
Patients of acute pancreatitis who have renal failure (Serum Creatinine > 1.5 mg/dl) at presentation
Patients who were contraindicated to Opioids and NSAIDS
Who already take Opioids and NSAIDS for other reasons
Patients with history of coronary artery disease
Patients with altered mental status
Patients with imaging evidence of chronic pancreatitis
Patients requiring ventilatory support
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method